Skip to content
About Us
Company Profile
Management
Investors
Contact
Research & Development
Mode of Action
Clinical Development
Publications
Vascular Integrity
Sepsis & Septic Shock
Adrenomedullin
News & Events
Press releases
Media coverage
Events
Career
About Us
Company Profile
Management
Investors
Contact
Research & Development
Mode of Action
Clinical Development
Publications
Vascular Integrity
Sepsis & Septic Shock
Adrenomedullin
News & Events
Press releases
Media coverage
Events
Career
Article in ENDPOINTS: Wellington, HBM lead €24M round as Adrenomed preps septic shock treatment for human testing
27. November 2018
November 2018
by Amber Tong.
Go to the article